⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

UK Stocks -- Factors to watch on Aug 20

Published 08/20/2009, 01:10 AM
Updated 08/20/2009, 01:15 AM
UK100
-
VED
-
RIO
-
GSK
-
SHI
-
SLT
-
HG
-
CL
-

LONDON, Aug 20 (Reuters) - Britain's FTSE 100 index is seen opening as much as 0.9 percent higher on Thursday, according to financial bookmakers, tracking gains in the U.S. and Asian markets.

"The European markets ended up pretty flat yesterday. But on the back of strong finish on Wall Street and on the strong showing in Asia, we are calling them up," said Matthew Buckland, a dealer at CMC Markets.

Financial spreadbetters expected the UK benchmark to open up 35 to 41 points, after closing up 3.89 points, or 0.1 percent at 4,689.67 on Wednesday.

U.S. stocks rose on Wednesday, shaking off a slide in China's equity market, as investors responded favourably to a surprising drop in crude oil stockpiles that might suggest an improving demand outlook. In Asia, Japan's Nikkei average gained 1.5 percent and Chinese stocks rose 2.1 percent. Heavyweight energy stocks would get a lift from firmer crude prices, which traded above $72 a barrel.

UK retail sales, due at 0830 GMT, will provide a gauge of the state of the British economy. Investors will shift their focus on U.S. weekly jobless claims later in the day.

* Wall St gains as oil data rekindles recovery hopes

* Nikkei up 0.7 percent, boosted by resources and China

* GLOBAL MARKETS-Shanghai stocks claw up but investor on edge

* Oil steady above $72 after 4 percent surge; eyes US data

* Yen edges lower as high-yielders back in favour

* TREASURIES-Futures off 1-mth peak as China shares rise

UK stocks to watch on Thursday are:

RIO TINTO

The miner is due to release its first-half results.

VEDANTA RESOURCES

Sterlite Industries, a unit of Vedanta Resources, has raised its offer for bankrupt U.S. copper miner Asarco LLC, making a bid that could pay unsecured creditors in full and compete with the latest offer from Mexican miner Grupo Mexico SAB de CV, according to an Asarco lawyer.

GLAXOSMITHKLINE

The U.S. Food and Drug Administration said on Wednesday it has approved GlaxoSmithKline's Hiberix Hib vaccines as a booster dose for children ages 15 months to four years.

SIG

The company is due to release its first-half results.

TODAY'S UK PAPERS

Financial Times

Other business headlines

(Reporting by Dominic Lau; Editing by Jon Loades-Carter)

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.